Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Frankel

Showing results (301-310 of 348) with videos related to

Pageof 35
Sort By:
Experimental Gerontology|October 30, 2017
Age-related immune responses after burn and inhalation injury are associated with altered clinical outcomesJohn H Frankel, Devin M Boe, Joslyn M Albright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PETJoanne E Mortimer, James R Bading, David M Colcher, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing MalignanciesDavid Akhavan, Paul Yazaki, Dave Yamauchi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 19, 2025
Real-world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysisPatrick McGown, Nikoleta Papanikolaou, Jasmine El-Taraboulsi, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 29, 2018
Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal AssociationA H Frankel, S Kazempour-Ardebili, R Bedi, et al.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast CancerJoanne E Mortimer, James R Bading, Jinha M Park, et al.
Plos One|November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survivalMichelle Afkhami, Daniel Schmolze, Susan E Yost, et al.
Pageof 35

Showing results (301-310 of 348) with videos related to

Sort By:
Pageof 35
Experimental Gerontology|October 30, 2017
Age-related immune responses after burn and inhalation injury are associated with altered clinical outcomesJohn H Frankel, Devin M Boe, Joslyn M Albright, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2013
Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PETJoanne E Mortimer, James R Bading, David M Colcher, et al.
Cancer Biotherapy & Radiopharmaceuticals|January 8, 2020
Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing MalignanciesDavid Akhavan, Paul Yazaki, Dave Yamauchi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 19, 2025
Real-world use of continuous glucose monitoring in people with type 2 diabetes and chronic kidney disease or on dialysisPatrick McGown, Nikoleta Papanikolaou, Jasmine El-Taraboulsi, et al.
Cancers|July 9, 2022
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast CancerJin Sun Lee, Susan E Yost, Sierra Min Li, et al.
The Oncologist|April 6, 2023
Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast CancerYuan Yuan, Susan E Yost, Yujie Cui, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|August 29, 2018
Management of adults with diabetes on the haemodialysis unit: summary of guidance from the Joint British Diabetes Societies and the Renal AssociationA H Frankel, S Kazempour-Ardebili, R Bedi, et al.
NPJ Breast Cancer|August 30, 2018
Sentinel lymph node B cells can predict disease-free survival in breast cancer patientsKim R M Blenman, Ting-Fang He, Paul H Frankel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2017
Tumor Uptake of <sup>64</sup>Cu-DOTA-Trastuzumab in Patients with Metastatic Breast CancerJoanne E Mortimer, James R Bading, Jinha M Park, et al.
Plos One|November 7, 2019
Mutation and immune profiling of metaplastic breast cancer: Correlation with survivalMichelle Afkhami, Daniel Schmolze, Susan E Yost, et al.
Pageof 35